文献速递白内障与屈光手术

对医疗保险白内障患者常规术前检查费用的修订估计:采用手术特异性指标

A Revised Estimate of Costs Associated With Routine Preoperative Testing in Medicare Cataract Patients With a Procedure-Specific Indicator.
PubMed 文献 · JAMA Ophthalmol · 2018-01-01

这项横断面研究分析了2011年接受门诊白内障手术的66岁以上医疗保险受益人的50%样本,以眼生物测量作为手术特异性指标标记常规术前检查窗口的起点,发现常规术前医学检查的发生频率和费用高于既往报告,额外费用归因于手术前30天窗口之前进行的检查。作者建议在白内障患者从眼生物测量到白内障手术的整个间期内避免常规术前医学检查。

要点

  • 共440857例患者接受白内障手术,其中423710例(96.1%)在指数手术前有眼生物测量记录。
  • 有生物测量记录的患者中,检查次数/患者/月从基线期的1.1增加至生物测量与手术间期的1.7。

核心结论

  • 在医疗保险受益人中,常规术前医学检查的发生频率和费用高于既往报告。
  • 额外费用归因于手术前30天窗口之前进行的检查。
  • 作为降低成本措施,白内障患者从眼生物测量到白内障手术的整个间期内应避免常规术前医学检查。

研究设计与样本

  • 横断面研究,评估2011年接受门诊白内障手术的66岁以上医疗保险受益人的50%样本的术前护理。
  • 数据分析于2016年3月至2017年10月完成。
  • 使用眼生物测量作为手术特异性指标标记常规术前检查窗口的起点,测量眼生物测量与白内障手术之间间期的检查率,并与生物测量前6个月的检查率比较。

主要发现

  • 共440857例患者接受白内障手术;423710例(96.1%)在指数手术前有眼生物测量记录,其中264514例(60.0%)为女性;队列平均(SD)年龄为76.1(6.2)岁。
  • 111998例(25.4%)在生物测量后超过30天接受手术。
  • 有生物测量记录的患者中,平均检查次数/患者/月从基线期的1.1增加至生物测量与白内障手术间期的1.7。
  • 所有患者在手术前30天检查达到峰值(1.8次/患者/月);生物测量后与手术前间期无重叠的子集患者在生物测量后30天检查率增至1.8次/患者/月,无论生物测量与手术之间间隔时间长短。

临床怎么用

  • 作者建议:作为降低成本措施,白内障患者从眼生物测量到白内障手术的整个间期内应避免常规术前医学检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Routine preoperative medical testing is not recommended for patients undergoing low-risk surgery, but testing is common before surgery. A 30-day preoperative testing window is conventionally used for study purposes; however, the extent of routine testing that occurs prior to that point is unknown. OBJECTIVE: To improve on existing cost estimates by identifying all routine preoperative testing that takes place after the decision is made to perform cataract surgery. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study assessed preoperative care in a 50% sample of Medicare beneficiaries older than 66 years who underwent ambulatory cataract surgery in 2011. Data analysis was completed from March 2016 to October 2017. MAIN OUTCOMES AND MEASURES: Using ocular biometry as a procedure-specific indicator to mark the start of the routine preoperative testing window, we measured testing rates in the interval between ocular biometry and cataract surgery and compared this with testing rates in the 6 months preceding biometry. We estimated the total cost of testing that occurred between biometry and cataract surgery. RESULTS: A total of 440 857 patients underwent cataract surgery. A total of 423 710 (96.1%) had an ocular biometry claim before index surgery, of whom 264 514 (60.0%) were female; the mean (SD) age of the cohort was 76.1 (6.2) years. A total of 111 998 (25.4%) underwent surgery more than 30 days after biometry. Among patients with a biometry claim, the mean number of tests/patient/month increased from 1.1 in the baseline period to 1.7 in the interval between biometry and cataract surgery. Although preoperative testing peaked in all patients in the 30 days preceding surgery (1.8 tests/patient/month), the subset of patients with no overlap between postbiometry and presurgery periods experienced increased testing rates to 1.8 tests per patient per month in the 30 days after biometry, regardless of the elapsed time between biometry and surgery. The total estimated cost of routine preoperative testing in the full cohort was $22.7 million; we estimate that routine preoperative testing costs Medicare up to $45.4 million annually. CONCLUSIONS AND RELEVANCE: In this study of Medicare beneficiaries, routine preoperative medical testing occurs more often and is costlier than has been reported previously. Extra costs are attributable to testing that occurs prior to the 30-day window preceding surgery. As a cost-cutting measure, routine preoperative medical testing should be avoided in patients with cataracts throughout the interval between ocular biometry and cataract surgery.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chen CL, Clay TH, McLeod S, et al. A Revised Estimate of Costs Associated With Routine Preoperative Testing in Medicare Cataract Patients With a Procedure-Specific Indicator. JAMA Ophthalmol. 2018. PMID: 29346472. doi:10.1001/jamaophthalmol.2017.6372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。